Close

Brean Capital Raises Price Target on Lemaitre Vascular (LMAT) to $20

July 28, 2016 10:14 AM EDT Send to a Friend
Brean Capital reiterated a Buy rating on LeMaitre Vascular (NASDAQ: LMAT), and raised the price target to $20.00 (from $17.50) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login